In last trading session, Kairos Pharma Ltd (AMEX:KAPA) saw 0.84 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.06 trading at $0.12 or 12.77% at ring of the bell on the day assigns it a market valuation of $14.52M. That closing price of KAPA’s stock is at a discount of -277.36% from its 52-week high price of $4.00 and is indicating a premium of 19.81% from its 52-week low price of $0.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 2.35 million if we extend that period to 3-months.

Kairos Pharma Ltd (AMEX:KAPA) trade information

Upright in the green during last session for gaining 12.77%, in the last five days KAPA remained trading in the green while hitting it’s week-highest on Friday, 04/04/25 when the stock touched $1.06 price level, adding 15.2% to its value on the day. Kairos Pharma Ltd’s shares saw a change of -30.26% in year-to-date performance and have moved 15.04% in past 5-day. Kairos Pharma Ltd (AMEX:KAPA) showed a performance of 1.92% in past 30-days. Number of shares sold short was 33043.0 shares which calculate 0.31 days to cover the short interests.

Kairos Pharma Ltd (AMEX:KAPA)’s Major holders

Insiders are in possession of 57.51% of company’s total shares while institution are holding 2.98 percent of that, with stock having share float percentage of 7.02%. Investors also watch the number of corporate investors in a company very closely, which is 2.98% institutions for Kairos Pharma Ltd that are currently holding shares of the company.